Small for gestational age: Adult metabolic and cardiovascular health and long-term safety of growth hormone treatment

Wesley Goedegebuure

Research output: Types of ThesisDoctoral ThesisInternal

50 Downloads (Pure)

Abstract

This thesis describes the concluding research that has been conducted in a large population of (young) adults who were born small for gestational age (SGA). Around 10% of children born SGA, do not experience catch-up growth, which leads to persistent short stature until adulthood. Growth hormone treatment and postponing puberty with gonadotropin-releasing hormone agonist (GnRHa) can lead to sufficient catch-up in height, which results in an adult height within the normal range. However, long-term effects of SGA birth, growth hormone and GnRHa treatment were unknown. We describe long-term effects of SGA birth and these treatments on metabolic and cardiovascular health, body composition, bone mineral density, kidney function, cognition and psychosocial functioning.
Original languageEnglish
Awarding Institution
  • Erasmus University Rotterdam
Supervisors/Advisors
  • Hokken - Koelega, A.C.S. (Anita), Supervisor
  • van der Steen, M (Manouk), Co-supervisor
Award date17 Sept 2021
Place of PublicationRotterdam
Print ISBNs978-94-6423-413-8
Publication statusPublished - 17 Sept 2021

Research programs

  • EMC MM-01-54-01

Fingerprint

Dive into the research topics of 'Small for gestational age: Adult metabolic and cardiovascular health and long-term safety of growth hormone treatment'. Together they form a unique fingerprint.

Cite this